Current Pharmaceutical Design
Title:Editorial: (Pharmaco)Metabolomics in Drug Discovery and Individualisation of Treatment
Volume: 23 Issue: 14
Author(s): Theodora Katsila*George P. Patrinos*
Affiliation:
- Department of Pharmacy University of Patras University Campus, 26504 Patras-Rio,Greece
- Department of Pharmacy University of Patras University Campus, 26504 Patras-Rio,Greece
Keywords: (Pharma)cometabolomics, pharmacogenetics, respiratory medicine, drug discovery, biomarker discovery, precision medicince
Export Options
About this article
Cite this article as:
Katsila Theodora*, Patrinos P. George*, Editorial: (Pharmaco)Metabolomics in Drug Discovery and Individualisation of Treatment, Current Pharmaceutical Design 2017; 23 (14) . https://dx.doi.org/10.2174/1381612823999170301112648
DOI https://dx.doi.org/10.2174/1381612823999170301112648 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Preface
Current Pharmaceutical Design Low Concentration of Salinomycin Prevents Regrowth and Partially Depletes Human Glioma Cells Surviving High Concentrations of Alkylating Agents
Clinical Cancer Drugs Meet Our Editorial Board Member
Current Metabolomics Postmenopausal Health of Indian Women: A Review
Current Women`s Health Reviews Substrates and Inhibitors of Human Multidrug Resistance Associated Proteins and the Implications in Drug Development
Current Medicinal Chemistry Applications of Mesoporous Materials as Excipients for Innovative Drug Delivery and Formulation
Current Pharmaceutical Design Role of Inflammation in the Development of Colorectal Cancer
Endocrine, Metabolic & Immune Disorders - Drug Targets MT1-MMP Activation of TGF-β Signaling Enables Intercellular Activation of an Epithelial-mesenchymal Transition Program in Cancer
Current Cancer Drug Targets Synthesis of Fluorescent Cysteine-gold Nano-clusters (Cys-Au-NCs) and their Application as Nano-biosensors for the Determination of Cysteine
Current Nanoscience Polymeric Nanocarriers: A New Horizon for the Effective Management of Breast Cancer
Current Pharmaceutical Design The Effect of Psychological Stress and Social Isolation on Neuroimmunoendocrine Communication
Current Pharmaceutical Design Different 6-Aryl-Fulvenes Exert Anti-proliferative effects on Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry The Role of Mitochondria in Cancer Induction, Progression and Changes in Metabolism
Mini-Reviews in Medicinal Chemistry Inorganic Nanoparticles for In Vitro Cancer Diagnosis: A Patent Review
Recent Patents on Nanomedicine Identification of Critical MicroRNA Gene Targets in Cervical Cancer Using Network Properties
MicroRNA Discovery of Hedgehog Antagonists for Cancer Therapy
Current Medicinal Chemistry Resistance to Crizotinib in Advanced Non-Small Cell Lung Cancer (NSCLC) with ALK Rearrangement: Mechanisms, Treatment Strategies and New Targeted Therapies
Current Clinical Pharmacology Anti-Tumor Monoclonal Antibodies in Conjunction with β-Glucans: A Novel Anti- Cancer Immunotherapy
Current Medicinal Chemistry Recent Progress in Biological Activities and Synthetic Methodologies of Pyrroloquinoxalines
Mini-Reviews in Medicinal Chemistry Inhibition of Cdc42-Interacting Protein 4 (CIP4) Impairs Osteosarcoma Tumor Progression
Current Cancer Drug Targets